DeWitt John M, Al-Haddad Mohammad, Stainko Sarah, Perkins Anthony, Fatima Hala, Ceppa DuyKhanh P, Birdas Thomas J
Gastroenterology and Hepatology, Indiana University Health Inc, Indianapolis, United States.
Biostatistics, Indiana University Health Inc, Indianapolis, United States.
Endosc Int Open. 2024 Jan 5;12(1):E43-E49. doi: 10.1055/a-2215-3415. eCollection 2024 Jan.
Gastroesophageal reflux disease (GERD) following peroral endoscopic myotomy (POEM) occurs in 40% to 60% of patients. There are limited data evaluating antireflux surgery or transoral incisionless fundoplication (TIF) for refractory post-POEM GERD. In a single-center prospective cohort study, consecutive patients with medically refractory post-POEM regurgitation and/or GERD treated with TIF or combined laparoscopic hernia repair and TIF (cTIF) were evaluated. Baseline evaluation: GERD-Health Related Quality of Life (GERD-HQRL) and Reflux Symptom Questionnaire 7-day recall (RESQ-7) questionnaires, EGD, high-resolution manometry (HRM), 48-hour pH test off proton pump inhibitors (PPIs) and impedance planimetry of the esophagogastric junction (EGJ) to calculate the diameter distensibility index (EGJ-DI). A PPI was taken twice daily for 2 weeks after TIF and restarted later if required. Patients returned 9 to 12 months after treatment when all preoperative studies were repeated. Quality of life, pH studies and EGJ metrics before and after antireflux surgery were compared. Seventeen patients underwent TIF (n=2, 12%) or cTIF (n=15, 88%) a mean 25±15 months after POEM. At follow-up a mean of 9±1 months after TIF/cTIF, patients required less frequent daily PPIs (n=0.001), were more satisfied (P=0.008), had improved GERD-HQRL (P=0.001), less intensity and frequency of GERD (P=0.001) and fewer reflux episodes (P=0.04) by pH testing. There was no change in EGJ-DI, EGJ diameter, integrated relaxation pressure, % total time pH <4, or DeMeester score. TIF and cTIF for difficult-to-control post-POEM GERD appear safe, decrease PPI use and reflux episodes, and improve QOL without significant change in IRP, EGJ compliance, diameter or esophageal acid exposure time.
经口内镜下肌切开术(POEM)后发生胃食管反流病(GERD)的患者比例为40%至60%。评估抗反流手术或经口无切口胃底折叠术(TIF)治疗POEM后难治性GERD的数据有限。在一项单中心前瞻性队列研究中,对连续接受TIF或联合腹腔镜疝修补术和TIF(cTIF)治疗的POEM后药物难治性反流和/或GERD患者进行了评估。基线评估:GERD健康相关生活质量(GERD-HQRL)问卷和反流症状问卷7天回顾(RESQ-7)、上消化道内镜检查(EGD)、高分辨率测压(HRM)、停用质子泵抑制剂(PPI)后的48小时pH测试以及食管胃交界处(EGJ)的阻抗平面测量以计算直径扩张指数(EGJ-DI)。TIF术后每天服用PPI两次,持续2周,如有需要可在之后重新开始服用。治疗后9至12个月患者复诊,重复所有术前检查。比较抗反流手术前后的生活质量、pH研究和EGJ指标。17例患者在POEM术后平均25±15个月接受了TIF(n = 2,12%)或cTIF(n = 15,88%)。在TIF/cTIF术后平均9±1个月的随访中,患者每日所需PPI的频率降低(n = 0.001),满意度提高(P = 0.008),GERD-HQRL改善(P = 0.001),GERD的强度和频率降低(P = 0.001),pH测试显示反流发作次数减少(P = 0.04)。EGJ-DI、EGJ直径、综合松弛压、pH <4的总时间百分比或DeMeester评分无变化。TIF和cTIF治疗POEM后难以控制的GERD似乎是安全的,可减少PPI使用和反流发作次数,并改善生活质量,而不会使下食管括约肌压力、EGJ顺应性、直径或食管酸暴露时间发生显著变化。